Drug Profile
Sudoterb
Alternative Names: LL-3858Latest Information Update: 23 Jul 2015
Price :
$50
*
At a glance
- Originator Lupin
- Class Antituberculars; Isonicotinic acids; Pyrroles
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 23 Jul 2015 No recent reports on development identified - Phase-II for Tuberculosis in India (unspecified route)
- 11 Dec 2013 Lupin completes a phase II trial in Tuberculosis in India prior to December 2013 (CTRI2009-091-000741)
- 31 Jul 2010 Lupin completes enrolment in its phase II trial for Tuberculosis in India (CTRI2009-091-000741)